0001776612-21-000002.txt : 20210609 0001776612-21-000002.hdr.sgml : 20210609 20210608195256 ACCESSION NUMBER: 0001776612-21-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210609 DATE AS OF CHANGE: 20210608 EFFECTIVENESS DATE: 20210609 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Akston Biosciences Corp CENTRAL INDEX KEY: 0001776612 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-384848 FILM NUMBER: 211003632 BUSINESS ADDRESS: STREET 1: 100 CUMMINGS CENTER SUITE 454C CITY: BEVERLY STATE: MA ZIP: 01915 BUSINESS PHONE: 978-969-3381 MAIL ADDRESS: STREET 1: 100 CUMMINGS CENTER SUITE 454C CITY: BEVERLY STATE: MA ZIP: 01915 D/A 1 primary_doc.xml X0708 D/A LIVE 0001776612 Akston Biosciences Corp 100 CUMMINGS CENTER SUITE 454C BEVERLY MA MASSACHUSETTS 01915 978-969-3381 DELAWARE None None Corporation true Todd C. Zion 100 CUMMINGS CENTER STE 454C BEVERLY MA MASSACHUSETTS 01915 Executive Officer Director Lovick E. Cannon 100 CUMMINGS CENTER STE 454C BEVERLY MA MASSACHUSETTS 01915 Director Thomas M. Lancaster 100 CUMMINGS CENTER STE 454C BEVERLY MA MASSACHUSETTS 01915 Executive Officer Director Robyn Davis 100 CUMMINGS CENTER STE 454C BEVERLY MA MASSACHUSETTS 01915 Director James M. Herriman 100 CUMMINGS CENTER STE 454C BEVERLY MA MASSACHUSETTS 01915 Executive Officer Biotechnology Decline to Disclose 06b true 0001776612-20-000002 2020-12-17 false true convertible promissory notes false 0 8000000 7876894 123106 false 71 0 0 0 false Akston Biosciences Corp /s/Todd C. Zion Todd C. Zion President and Chief Executive Officer 2021-06-07